Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The primary objective was to investigate whether multiple-dose administration of ESL 800 mg
once daily affects the pharmacokinetics of simvastatin, a substrate of CYP34A.